Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.
Artemisinin-based combination therapies are the most effective drugs to treat Plasmodium falciparum malaria. Reduced sensitivity to artemisinin monotherapy, coupled with the emergence of parasite resistance to all partner drugs, threaten to place millions of patients at risk of inadequate treatment...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
_version_ | 1797061384591114240 |
---|---|
author | Fairhurst, R Nayyar, G Breman, J Hallett, R Vennerstrom, J Duong, S Ringwald, P Wellems, T Plowe, C Dondorp, A |
author_facet | Fairhurst, R Nayyar, G Breman, J Hallett, R Vennerstrom, J Duong, S Ringwald, P Wellems, T Plowe, C Dondorp, A |
author_sort | Fairhurst, R |
collection | OXFORD |
description | Artemisinin-based combination therapies are the most effective drugs to treat Plasmodium falciparum malaria. Reduced sensitivity to artemisinin monotherapy, coupled with the emergence of parasite resistance to all partner drugs, threaten to place millions of patients at risk of inadequate treatment of malaria. Recognizing the significance and immediacy of this possibility, the Fogarty International Center and the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health convened a conference in November 2010 to bring together the diverse array of stakeholders responding to the growing threat of artemisinin resistance, including scientists from malarious countries in peril. This conference encouraged and enabled experts to share their recent unpublished data from studies that may improve our understanding of artemisinin resistance. Conference sessions addressed research priorities to forestall artemisinin resistance and fostered collaborations between field- and laboratory-based researchers and international programs, with the aim of translating new scientific evidence into public health solutions. Inspired by this conference, this review summarizes novel findings and perspectives on artemisinin resistance, approaches for translating research data into relevant public health information, and opportunities for interdisciplinary collaboration to combat artemisinin resistance. |
first_indexed | 2024-03-06T20:30:21Z |
format | Journal article |
id | oxford-uuid:30d491e2-6e08-4a25-acd3-5fd5b6b084c1 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T20:30:21Z |
publishDate | 2012 |
record_format | dspace |
spelling | oxford-uuid:30d491e2-6e08-4a25-acd3-5fd5b6b084c12022-03-26T13:03:58ZArtemisinin-resistant malaria: research challenges, opportunities, and public health implications.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:30d491e2-6e08-4a25-acd3-5fd5b6b084c1EnglishSymplectic Elements at Oxford2012Fairhurst, RNayyar, GBreman, JHallett, RVennerstrom, JDuong, SRingwald, PWellems, TPlowe, CDondorp, AArtemisinin-based combination therapies are the most effective drugs to treat Plasmodium falciparum malaria. Reduced sensitivity to artemisinin monotherapy, coupled with the emergence of parasite resistance to all partner drugs, threaten to place millions of patients at risk of inadequate treatment of malaria. Recognizing the significance and immediacy of this possibility, the Fogarty International Center and the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health convened a conference in November 2010 to bring together the diverse array of stakeholders responding to the growing threat of artemisinin resistance, including scientists from malarious countries in peril. This conference encouraged and enabled experts to share their recent unpublished data from studies that may improve our understanding of artemisinin resistance. Conference sessions addressed research priorities to forestall artemisinin resistance and fostered collaborations between field- and laboratory-based researchers and international programs, with the aim of translating new scientific evidence into public health solutions. Inspired by this conference, this review summarizes novel findings and perspectives on artemisinin resistance, approaches for translating research data into relevant public health information, and opportunities for interdisciplinary collaboration to combat artemisinin resistance. |
spellingShingle | Fairhurst, R Nayyar, G Breman, J Hallett, R Vennerstrom, J Duong, S Ringwald, P Wellems, T Plowe, C Dondorp, A Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. |
title | Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. |
title_full | Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. |
title_fullStr | Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. |
title_full_unstemmed | Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. |
title_short | Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. |
title_sort | artemisinin resistant malaria research challenges opportunities and public health implications |
work_keys_str_mv | AT fairhurstr artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications AT nayyarg artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications AT bremanj artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications AT hallettr artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications AT vennerstromj artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications AT duongs artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications AT ringwaldp artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications AT wellemst artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications AT plowec artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications AT dondorpa artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications |